Mangalore Refinery and Petrochemicals Limited (MRPL) has announced the launch of its Toluene production facility during a visit by the Hon’ble Minister of Petroleum and Natural Gas, Shri Hardeep Singh Puri, to its refinery. This milestone aligns with India’s vision of self-reliance and global competitiveness in the petrochemical sector.

Significant Contribution to Domestic Toluene Production

With an annual production capacity of 40 TMT, MRPL’s Toluene facility marks a substantial step toward reducing India’s dependency on imports. Currently, the domestic production of Toluene stands at 160 TMT against a demand of approximately 650 TMT per year. MRPL’s addition will help address this gap while saving $3 million annually in foreign exchange.

Toluene, a versatile aromatic hydrocarbon, is essential for industries such as pharmaceuticals, chemicals, paints, and defence. By enhancing domestic production, MRPL strengthens India’s industrial supply chain, enabling growth in key sectors.

The initiative is a testament to India’s progress toward becoming self-reliant in critical resources. MRPL’s efforts will not only boost the economy but also reduce dependency on imports, supporting industrial and economic growth in line with the Atmanirbhar Bharat mission.

On January 13, 2025, MRPL share price opened at ₹139.00, touching the day’s high at ₹144.44, as of 9:47 AM on the NSE.

 

Disclaimer: This blog has been written exclusively for educational purposes. The securities mentioned are only examples and not recommendations. This does not constitute a personal recommendation/investment advice. It does not aim to influence any individual or entity to make investment decisions. Recipients should conduct their own research and assessments to form an independent opinion about investment decisions.

Investments in the securities market are subject to market risks, read all the related documents carefully before investing.

Wockhardt Limited informed the exchanges that in a groundbreaking clinical study, Zaynich® demonstrated exceptional efficacy, with over 97% clinical success in treating patients with infections caused by carbapenem-resistant Gram-negative pathogens, including meropenem-resistant strains.

Zaynich® is Wockhardt’s novel proprietary antibiotic that combines Zidebactam and Cefepime (WCK 5222).

The study addressed severe infections such as hospital-acquired bacterial pneumonia (HABP), ventilator-associated bacterial pneumonia (VABP), bloodstream infections (BSI), complicated intra-abdominal infections (cIAI), and complicated urinary tract infections (cUTI). For bloodstream infections, HABP/VABP, and cIAI, Zaynich® achieved a remarkable 100% clinical efficacy.

High Efficacy and Pathogen Eradication Rates

Zaynich® also achieved notable pathogen eradication rates, including 91% for HABP/VABP and 100% for bloodstream infections. The study included critically ill patients across 15 tertiary care hospitals in India, focusing exclusively on carbapenem-resistant Gram-negative infections caused by pathogens like Acinetobacter spp., Pseudomonas spp., Klebsiella spp., and E. coli.

Using advanced molecular diagnostic technologies, the study highlighted Zaynich®’s effectiveness even against extensively drug-resistant (XDR) infections. Treatment durations ranged from 7 to 21 days, with the protocol receiving approval from the Drugs Controller General of India (DCGI).

Addressing the Global Threat of Antimicrobial Resistance

Zaynich® emerges as a game-changer in the fight against antimicrobial resistance (AMR), a growing global threat. Unlike current options such as colistin and polymyxins, which have significant toxicity and limited efficacy, Zaynich® provides a safer and more effective alternative.

It targets critical Gram-negative pathogens identified by the CDC and WHO, making it a valuable tool in combating life-threatening infections. With over 100 critically ill patients saved through its compassionate use in India and the US, Zaynich® sets a new benchmark for treating drug-resistant infections, offering hope for improved patient outcomes worldwide.

On January 13, 2025, Wockhardt share price (NSE: WOCKPHARMA) opened at ₹1,380.00, touching the day’s high at ₹1,442.00, as of 9:58 AM on the NSE.

 

Disclaimer: This blog has been written exclusively for educational purposes. The securities mentioned are only examples and not recommendations. This does not constitute a personal recommendation/investment advice. It does not aim to influence any individual or entity to make investment decisions. Recipients should conduct their own research and assessments to form an independent opinion about investment decisions.

Investments in the securities market are subject to market risks, read all the related documents carefully before investing.

On January 13, 2025, as of 12 PM, the BSE Sensex was down 619.83 points (-0.80%) at 76,759.08, while the Nifty50 was down by 205.05 points (-0.88%) at 23,225.90. Among sectors, only the Nifty Realty dropped 4.29%.

As of January 13, 2025, 12:03 IST, the mid-day top gainers and losers are:

Mid-Day Top Gainers 

• Axis Bank

Axis Bank share price rose 1.43%, opening at ₹1,026.60 and touching the day’s high at ₹1,063.00.

• IndusInd Bank

IndusInd Bank share price gained 1.34%, opening at ₹936.90 and touching the day’s high at ₹973.50.

• TCS

Tata Consultancy Services share price surged 0.95%, opening at ₹4,245.00, hitting a high of ₹4,316.80.

• Shriram Finance

Shriram Finance share price surged 0.49%, opening at ₹530.05, hitting a day’s high of ₹540.70.

• Infosys 

Infosys Share Price rose by 0.11%, opening at ₹1,956.00, hitting a day’s high of ₹1,982.80.

Mid-Day Top Losers

• Trent

Trent share price dropped 5.11%, opening at ₹6,462.65. The stock touched its day’s low at ₹6,228.55.

• Adani Enterprises 

Adani Enterprises Share Price fell 3.11%, opening at ₹2,365.00. The stock touched its day’s low at ₹2,295.00.

• Apollo Hospitals Enterprise

Apollo Hospitals share price dropped 2.99%, opening at ₹7,000.00. The stock touched its day’s low at ₹6,812.05.

• Grasim Industries

Grasim Industries share price slipped 2.33%, opening at ₹2,329.95. The stock touched its day’s low at ₹2,302.00.

• Eicher Motors

Eicher Motors share price slipped 2.39%, opening at ₹5,010.00. The stock touched its day’s low at ₹4,930.00.

 

Disclaimer: This blog has been written exclusively for educational purposes. The securities mentioned are only examples and not recommendations. This does not constitute a personal recommendation/investment advice. It does not aim to influence any individual or entity to make investment decisions. Recipients should conduct their own research and assessments to form an independent opinion about investment decisions.

Investments in the securities market are subject to market risks, read all the related documents carefully before investing.

CESC Ltd has been in focus on Monday. On January 13, 2025, CESC share price opened at ₹161.00, down from its previous close of ₹162.42. At 11:27 AM, the share price of CESC was trading at ₹157.07, down by 3.29% on the NSE. As of the same time, the stock touched its day’s low at ₹152.77.

Q3 FY 2025 Financial Highlights 

On January 10, 2025, the company provided an update for the third quarter of FY 2025. For Q3 FY25, the company reported gross revenue of ₹3,657 crore, reflecting a growth of 10.8% compared to ₹3,301 crore in Q3 FY24. The EBITDA for the quarter stood at ₹1,006 crore, an increase of 4.5% over ₹963 crore in the same quarter last year. However, the PAT (Profit After Tax) decreased by 6.3%, coming in at ₹282 crore, down from ₹301 crore in Q3 FY24.

For the nine-month period of FY25, the company reported a gross revenue of ₹13,345 crore, marking a 10.4% increase from ₹12,084 crore in the same period last year. The EBITDA for 9MFY25 stood at ₹3,206 crore, up by 4.1% from ₹3,079 crores in 9MFY24. PAT for the nine months was ₹1,043 crore, an increase of 1.1% compared to ₹1,032 crore in the previous year.

Interim Dividend Declaration and Record Date

The company has declared an interim dividend of ₹4.50 per equity share (i.e., 450%) on its paid-up equity share capital. This dividend will be payable to members whose names are listed in the Register of Members or those who appear as beneficial owners, as per the details provided by the Depositories, namely National Securities Depository Limited (NSDL) and Central Depository Services (India) Limited (CDSL), as of the close of business on January 16, 2025, the Record Date to determine eligibility for the interim dividend.

 

Disclaimer: This blog has been written exclusively for educational purposes. The securities mentioned are only examples and not recommendations. This does not constitute a personal recommendation/investment advice. It does not aim to influence any individual or entity to make investment decisions. Recipients should conduct their own research and assessments to form an independent opinion about investment decisions.

Investments in the securities market are subject to market risks, read all the related documents carefully before investing.

IndusInd Bank Limited is in focus on Monday. On January 13, 2025, IndusInd Bank share price opened at ₹936.90, down from its previous close of ₹937.60. However, at 11:04 AM, the share price of IndusInd Bank was trading at ₹962.50, up by 2.66% on the NSE. As of the same time, the stock touched its day’s high at ₹973.50.

In December 2024, IndusInd Bank celebrated its 30th anniversary, marking three decades of leading technological advancements and digital innovations that have shaped the future of banking in India. To commemorate this milestone, the Bank announced its partnership with India Post to launch Customised My Stamps.

Financial Highlights for the Quarter ended September 30, 2024

For the quarter ended September 30, 2024, Net Interest Income stood at ₹5,347 crore, marking a 5% YoY growth. The Net Interest Margin (NIM) for Q2 FY 2025 was 4.08%, compared to 4.29% in Q2 FY 2024 and 4.25% in Q1 FY 2025. The decrease in NIM was primarily due to a reduction in the share of microfinance loans in the overall loan portfolio.

The Yield on Assets remained consistent at 9.69% for both the quarter ended September 30, 2024, and the same period in the previous year. The Cost of Funds increased to 5.61%, from 5.40% in the corresponding quarter of the previous year.

Other income for the quarter was ₹2,185 crores, compared to ₹2,282 crores in the same quarter last year. Core Fee income was ₹2,125 crores, slightly higher than ₹2,120 crores reported in the corresponding quarter of the previous year.

Operating expenses for the quarter were ₹3,932 crores, up from ₹3,450 crores in the same quarter of the previous year.

 

Disclaimer: This blog has been written exclusively for educational purposes. The securities mentioned are only examples and not recommendations. This does not constitute a personal recommendation/investment advice. It does not aim to influence any individual or entity to make investment decisions. Recipients should conduct their own research and assessments to form an independent opinion about investment decisions.

Investments in the securities market are subject to market risks, read all the related documents carefully before investing.

HCL Technologies Limited (HCLTech) is gaining attention on Monday ahead of the Q3 FY 2025 financial results announcement. On January 13, 2025, HCL share price (NSE: HCLTECH) opened at ₹1,994.90, slightly down from its previous close of ₹1,995.10. At 10:10 AM, the share price of HCLTech was trading at ₹1,985.30, down by 0.49% on the NSE. Notably, the stock touched its 52-week high at ₹2,002.35 recently on January 10, 2025.

Board Meeting Announcement and Interim Dividend Declaration

In December 2024, the company announced that its Board of Directors would convene on Monday, January 13, 2025, to discuss key financial matters. The meeting’s agenda includes the review of the unaudited financial results for the quarter and the nine months ending December 31, 2024, along with the consideration of the 4th Interim Dividend for the financial year 2024-25.

Financial Performance in Q2 FY 2025

For Q2 FY 2025, the company’s revenue reached ₹28,862 crore, reflecting a growth of 2.9% quarter-on-quarter (QoQ) and 8.2% year-on-year (YoY). The Earnings Before Interest and Tax (EBIT) stood at ₹5,362 crore, which constitutes 18.6% of the total revenue, showing a 11.8% increase QoQ and an 8.7% rise YoY.

During the second quarter, the Board declared an Interim Dividend of ₹12 per equity share for the financial year 2024-25. The Record Date for this dividend was set for October 22, 2024, with the payment date scheduled for October 30, 2024.

 

 

Disclaimer: This blog has been written exclusively for educational purposes. The securities mentioned are only examples and not recommendations. This does not constitute a personal recommendation/investment advice. It does not aim to influence any individual or entity to make investment decisions. Recipients should conduct their own research and assessments to form an independent opinion about investment decisions.

Investments in the securities market are subject to market risks, read all the related documents carefully before investing.

Delta Corp Ltd is in focus on Monday ahead of the Q3 FY 2025 financial results announcement. On January 13, 2025, Delta Corp share price (NSE: DELTACORP) opened at ₹117.00, slightly down from its previous close of ₹118.93. At 10:32 AM, the share price of Delta Corp was trading at ₹114.22, down by 3.96% on the NSE. As of the same time, the stock touched its day’s low at ₹113.76.

Board Meeting Announcement

Earlier this month, in January 2025, the company announced that its Board of Directors would convene on Monday, January 13, 2025, to review the unaudited financial results for the quarter and the nine months ending December 31, 2024.

Financial Performance in Q2 FY 2025

For Q2 FY 2025, the company’s total income reached ₹206.17 lakh, dropping from ₹273.14 lakh in Q2 FY 2024. The profit for the period stood at ₹26.98 lakh, dropping from ₹69.44 lakh in Q2 FY 2024.

About Delta Corp Ltd

Delta Corp Limited is involved in the businesses of gaming (live, electronic and online), hospitality and real estate. The company has evolved into diversified segments like real estate, casino gaming, online gaming, and hospitality.

 

Disclaimer: This blog has been written exclusively for educational purposes. The securities mentioned are only examples and not recommendations. This does not constitute a personal recommendation/investment advice. It does not aim to influence any individual or entity to make investment decisions. Recipients should conduct their own research and assessments to form an independent opinion about investment decisions.

Investments in the securities market are subject to market risks, read all the related documents carefully before investing.

India is recognised as one of the most popular travel destinations worldwide. It has led the country’s tourism and hospitality industry to become a major growth driver in the services sector. With tourism being a key source of foreign exchange, India’s industry holds significant potential. In 2021, the travel and tourism sector contributed US$ 178 billion to the GDP, and it is projected to reach US$ 512 billion by 2028. By 2029, the sector is expected to generate ~53 million jobs. In this article, check the best travel stocks in India for January 2025, based on the net profit margin.

Best Travel Stocks in India for January 2025 – Net Profit Margin Basis

Note: The best travel stocks in India listed here as of market cap with above ₹1,000 crore and are sorted based on the net profit margin. The data is as of January 10, 2025.

Overview of the Best Travel Stocks in India

1. Easy Trip Planners Ltd

Easy Trip Planners provides a comprehensive range of travel-related products and services under the “Ease My Trip” brand. It offers end-to-end travel solutions, including airline tickets, hotels, holiday packages, rail and bus tickets, taxis, and value-added services like travel insurance, visa processing, and tickets for activities and attractions.

In H1 FY25, the company reported revenue from operations of ₹2,972.7 million, compared to ₹2,657.5 million in H1 FY24. The Profit After Tax (PAT) for H1 FY25 was ₹607.3 million, down from ₹728.6 million in H1 FY24.

Key metrics:

• ROE: 20.73%

• ROCE: 23.20%

2. Tbo Tek Ltd

TBO Tek Ltd is involved in the business of operating multiple online technology platforms and offering access to book global travel inventory aggregated through travel suppliers like airlines, hotels, etc. In H1 FY25, revenue from operations was ₹869 crore, up 25% YoY from ₹697 crore. PAT stood at ₹121 crore, reflecting a 17% YoY growth from ₹103 crore, with a PAT margin of 14%.

Key metrics:

• ROE: 45.84%

• ROCE: 30.80%

3. India Tourism Development Corp Ltd

India Tourism Development Corporation Ltd, established in October 1966, is a Government of India undertaking. The company operates hotels and restaurants, offers transport services, produces and sells tourist publicity literature, and provides entertainment and duty-free shopping facilities to tourists. In H1 FY25, revenue from operations was ₹23,856.59 lakh, dropping from ₹24,920.37 lakh in H1 FY24. Net profit stood at ₹3,536.37 lakh, which declined from ₹3,619.68 lakh in H1 FY24.

Key metrics:

• ROE: 19.92%

• ROCE: 27.47%

4. ECOS (India) Mobility & Hospitality Ltd

ECOS (India) Mobility & Hospitality Limited is a chauffeur-driven car rental service provider in India. In H1 FY25, revenue from operations was ₹3,084.76 million, up 14.88% YoY from ₹2,685.13 million. PAT stood at ₹292.53 million, with a 3.82% YoY drop from ₹304.14 million.

Key metrics:

• ROE: 42.74%

• ROCE: 43.90%

5. Thomas Cook (India) Ltd

Thomas Cook provides a broad spectrum of services that include corporate travel, foreign exchange, MICE, leisure travel, visa & passport services, etc. The company’s total income from operations increased by 10% to ₹41,764 million for H1 FY25, compared to ₹37,937 million in H1 FY24. Consolidated PBT rose by 26% to ₹2,136 million in H1 FY25, from ₹1,689 million in H1 FY24.

Key metrics:

• ROE: 13.98%

• ROCE: 14.89%

Tourism and Hospitality Sector Growth in India 

The travel market in India is forecasted to grow from an estimated US$ 75 billion in FY20 to US$ 125 billion by FY27. The Indian airline sector, valued at ~US$ 20 billion, is expected to double by FY27, supported by enhanced airport infrastructure and better access to passports.

The Indian hotel market, including domestic, inbound, and outbound, was estimated at around US$ 32 billion in FY20 and is projected to reach about US$ 52 billion by FY27, driven by increasing demand from travellers and the efforts of travel agents. By 2028, international tourist arrivals are anticipated to hit 30.5 billion, generating over US$ 59 billion in revenue.

 

Disclaimer: This blog has been written exclusively for educational purposes. The securities mentioned are only examples and not recommendations. This does not constitute a personal recommendation/investment advice. It does not aim to influence any individual or entity to make investment decisions. Recipients should conduct their own research and assessments to form an independent opinion about investment decisions.

Investments in the securities market are subject to market risks, read all the related documents carefully before investing.